America’s First Therapeutic Cancer Vaccine
Last Thursday the Food and Drug Administration approved Provenge for the treatment of advanced prostate cancer. Provenge is the first therapeutic vaccine to be approved in the U.S. for cancer treatment, ushering in what may be a new era in immune-based cancer treatments. Approval marks the successful conclusion of a 20-year odyssey with some remarkable twists and turns. My part of the story …
Read more on The Atlantic
Cancer linked to our food
AN alarming US cancer report calls for the removal of toxins from food and water, warning the risk from chemicals was underestimated.
Read more on Herald Sun
Ze-Guang Han and colleagues, at the Chinese National Human Genome Center at Shanghai, People’s Republic of China, have now identified SCARA5 as a candidate tumor suppressor gene in human hepatocellular carcinoma (HCC), a form of liver cancer that is the fifth most common cancer worldwide.
The research is reported in the Journal of Clinical Investigation.
» Read more: New Suppressor of Common Liver Cancer